Innovation Pharmaceuticals Inc (IPIX)

[Golfguru03]

Personally I thought the PR was great news in that the comparator is Vancomycin and Zyvox which is considered the Standard of Care for treating ABSSI and MRSA (which can lead to sepsis)...Brilacidin has already gone up against Dapto and proved superior with it's single dose application...

The company is following the FDA's guide lines to a T for the protocol for this phase III trial. This will lead to fastest possible approval as well as attract multiple potential partners sooner rather than later.

Some may have to put on their "half empty" glasses and reread the notice.

I am a buyer today.

All IMO.

Mark